<DOC>
	<DOCNO>NCT02518672</DOCNO>
	<brief_summary>Monoglyceride DHA ( DHA-MAG ) lipid compound intestinal absorption would increase ratio DHA / arachidonic acid ( AA ) promote synthesis specific metabolites involved resolution inflammation . The PREMDIC project , initiate Centre Hospitalier Universitaire de Sherbrooke , randomize double-blind study people cystic fibrosis ( CF ) aim evaluate whether daily supplementation monoglyceride DHA ( fatty acid omega-3 family ) reduce lung inflammation improve pulmonary function .</brief_summary>
	<brief_title>Pro-resolving Effect MAG-DHA Cystic Fibrosis ( PREMDIC )</brief_title>
	<detailed_description>The goal study : To investigate efficacity oral administration MAG-DHA increase DHA bioavailability reduce lung inflammation patient cystic fibrosis The specific objective project : - Determine effect MAG-DHA lipid membrane blood mononuclear cell . - Evaluate effect MAG-DHA lung inflammation ( determination Human leukocyte elastase alpha1 antitrypsin complex : pHLE ) . For study , 20 cystic fibrosis patient recruit . Patients divide 2 group 10 receive daily dose equivalent 3 g placebo ( sunflower oil ) MAG-DHA . The project take place period 3 month patient must travel research center total five visit include recruitment . For 2 group , DHA ratio / AA measure membrane mononuclear cell . Forced expiratory volume 1 second ( FEV1 ) determine pHLE complex detect plasma marker inflammation .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>1. forced expiratory volume 1 second ( FEV1 ) 30 90 % . 2. respiratory exacerbation last 2 week start study 3. clot problem history bleed diathesis 4. patient liver function abnormality include study 1. pregnant woman use contraception . 2. know allergy fish / seafood .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>